Home | Welcome to Contract Pharma   
Last Updated Friday, May 24 2013
Print

Promotions & Moves

Related Searches:

Filter by:

IndiPharm
December 5, 2008
Nigel McBean has been named vice president and director of operations at IndiPharm's operational headquarters in Mumbai, India. Mr. McBean will be responsible for all operational activities, including identification and recruitment of investigators a…   Read More »
FibroGen
December 5, 2008
K. Peony Yu, M.D., has been named vice president, clinical development at FibroGen. Dr. Yu has expertise in design and execution of all phases of clinical development programs, including clinical and regulatory strategy, interactions with regulatory…   Read More »
Camargo Pharmaceutical Services
December 4, 2008
Elaine Taylor has been named director of research services at Camargo Pharmaceutical Services. Ms. Taylor will perform all scientific research writing activities and provide full life-cycle support from clinical study protocols through regulatory sub…   Read More »
GVK Biosciences
December 4, 2008
Dr. Shoibal Mukherjee has been named senior vice president – Clinical Development, at GVK Biosciences Pvt. Ltd. William Harel, Ph.D. has been named vice president – Business Development, West Coast USA. Prior to joining GVK BIO, Dr. Mu…   Read More »
Ricerca
December 3, 2008
Thomas Davidson, Ph.D., has been appointed director of toxicology and pharmacology, Ricerca. Dr. Davidson is responsible for the company's study directors, peer review of toxicological reports and ensuring on-time delivery of these reports.  &…   Read More »
Sparta Systems
December 2, 2008
Sparta Systems, Inc. has added two software industry veterans to drive global expansion efforts. Tom Dalle-Molle, vice president of North American sales, and Nathan Birtle, vice president of EMEA and APAC sales, will use their enterprise solutions ex…   Read More »
Wyeth Pharmaceuticals
November 26, 2008
Christian Velmer has been appointed president and managing director of Wyeth Canada, effective November 17, 2008. Mr. Velmer replaces Arnout Ploos Van Amstel, who has taken a position as senior vice president and general manager, Institutional Busine…   Read More »
Wyeth
November 21, 2008
Michael Kamarck, Ph.D., has been promoted to president, Technical Operations & Product Supply (TO&PS), Wyeth. Dr. Kamarck will be responsible for all aspects of technical operations and product supply for the company, including its Pharmaceut…   Read More »
Elan Corp.
November 20, 2008
Carlos V. Paya, M.D., Ph.D., will be named president, Elan Corporation, plc on November 25, 2008. Dr. Paya will be based at Elan’s South San Francisco campus, with particular focus on and responsibility for leading the company’s scientifi…   Read More »
AstraZeneca
November 18, 2008
Rich Fante has been named president of AstraZeneca's U.S. business. Mr. Fante takes over from Tony Zook, whose role was expanded after recently being named president of MedImmune, AZ's wholly-owned biologics business. Mr. Zook is chief executive offi…   Read More »
PDI, Inc.
November 18, 2008
Nancy Lurker has been named chief executive officer of PDI, Inc., a provider of contract sales and commercial services to the biopharmaceutical industry. She was also named to the board of directors. Ms. Lurker previously served as senior vice pre…   Read More »
MedImmune
November 13, 2008
Tony Zook has been appointed president of MedImmune. Mr. Zook was previously responsible for heading the company on an interim basis. MedImmune is the wholly owned biologics business for AstraZeneca and in addition to MedImmune, Mr. Zook is responsib…   Read More »
Alexion Pharmaceuticals, Inc.
November 11, 2008
David W. Keiser, will retire from his position as president of Alexion Pharmaceuticals by the end of this year. Mr. Keiser, a co-founder of Alexion, played a central role in the commercial launch of Soliris in the U.S. and Europe, and helped to build…   Read More »
QSV Biologics Ltd.
October 31, 2008
Rod Szarka has been appointed business development manager, QSV Biologics Ltd. He will be responsible for new business in California. Mr. Szarka has more than16 years of experience in drug research and development and four years of business developme…   Read More »
Irvine Pharmaceutical Services
October 30, 2008
Aryo Nikopour has been named vice president of scientific and technical services, and Greg McParland has been named chief operating officer at Irvine Pharmaceutical Services. These changes were made to accommodate the company’s growth, as well…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: